CDA3C660-4E3F-4721-8F1B-A0E87941E356 Created with sketchtool.
Resource Center
December 1, 2020
Vectorious’ in-heart microcomputer wins FDA breakthrough nod
Mass Device
FDA Breakthrough Device Designation is granted to devices that have the potential to offer a “more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases.”
November 1, 2020
Startups Magazine
October 27, 2020
1 out of 21 Worldwide: Eldar's In-heart Microcomputer
Ynet (Hebrew)
October 26, 2020
"I did not see myself developing another chip sitting in the box, I wanted to develop something with impact"
Calcalist (Hebrew)
Oren Goldshtein, Vectorious CEO, speaks to Navot Volk and Aviv Frenkel, Calcalist – one of Israel’s leading financial news outlets – to discuss the Vectorious story.
October 8, 2020
10 Health Tech Startups Shaping the Future of Healthcare In the UK
Maddyness UK
October 6, 2020
A mini computer in-heart: The next stage of monitoring chronic patients
Globes (Hebrew)
October 1, 2020
Why absence could make your heart go longer
As Britain sees a gradual shift towards so-called remote medicine, we take a look at the inventions that are changing the face of cardiac care
August 3, 2020
Reimagining remote care for patients with heart failure
Science and Business
An Israeli start-up wins investor and EU interest with a device to monitor severely ill heart patients at home – improving care and outcomes
July 21, 2020
“Our Business Will Save Millions Of Lives and Billions of Pounds"
Here is the story of ‘entrepreneurs’ with an idea so massive and apparently out of reach, that it took them years of hard work before they knew their goal was even possible
July 18, 2020
This Israeli startup helps predict heart failure before it happens
The Israeli startup's small minimally-invasive device allows doctors a remote way to better predict and care for a patient with heart failure
Thank you for subscribing!

Get our latest news and updates!

Subscribe to get Vectorious' Newsletter with the latest news and clinical updates from the VECTOR-HF study